Growth Metrics

Novartis Ag (NVS) Current Assets (2016 - 2025)

Historic Current Assets for Novartis Ag (NVS) over the last 17 years, with Q4 2025 value amounting to $30.5 billion.

  • Novartis Ag's Current Assets rose 254.51% to $30.5 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $30.5 billion, marking a year-over-year increase of 254.51%. This contributed to the annual value of $30.5 billion for FY2025, which is 254.51% up from last year.
  • As of Q4 2025, Novartis Ag's Current Assets stood at $30.5 billion, which was up 254.51% from $28.2 billion recorded in Q3 2025.
  • Over the past 5 years, Novartis Ag's Current Assets peaked at $45.7 billion during Q4 2021, and registered a low of $22.2 billion during Q1 2021.
  • Its 5-year average for Current Assets is $31.6 billion, with a median of $30.5 billion in 2023.
  • As far as peak fluctuations go, Novartis Ag's Current Assets surged by 6774.48% in 2022, and later plummeted by 3152.87% in 2024.
  • Quarter analysis of 5 years shows Novartis Ag's Current Assets stood at $45.7 billion in 2021, then decreased by 19.27% to $36.9 billion in 2022, then fell by 17.42% to $30.5 billion in 2023, then fell by 2.55% to $29.7 billion in 2024, then rose by 2.55% to $30.5 billion in 2025.
  • Its Current Assets was $30.5 billion in Q4 2025, compared to $28.2 billion in Q3 2025 and $25.9 billion in Q2 2025.